Eli Lilly is moving to deepen its bet on inflammatory disease, striking a deal to acquire biotech player Ventyx Biosciences ...

Notably, the paper also includes simulation studies outlining when dDRTC is most effective, positioning it as a practical ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission. TL;DR: A wide range of ...

A collection of summaries and reflective notes from immunology courses, including innate and adaptive immunity, autoimmunity, infectious diseases, cancer immunology and immune system failures.

A collection of summaries and reflective notes from immunology courses, including innate and adaptive immunity, autoimmunity, infectious diseases, cancer immunology and immune system failures.

AbbVie Inc., 2 hours ago, published monstrous results for Q3, once again strengthening my confidence that it is a "powerhouse" in the autoimmune disease drugs market. Net revenues from AbbVie's ...

Good morning and good afternoon, and welcome to the Novartis Immunology Portfolio Update Conference Call and Live Webcast. [Operator Instructions] The conference is being recorded. [Operator ...

At the University of Virginia School of Medicine, Kristin Anderson’s passion for cancer research stems from her own experiences with the disease and witnessing firsthand the power of scientific ...

Stockholm — Mary E. Brunkow, Fred Ramsdell and Dr. Shimon Sakaguchi won the Nobel Prize in medicine on Monday for their discoveries concerning peripheral immune tolerance. Brunkow, 64, is a senior ...

Mary Brunkow, senior program manager at the Institute for Systems Biology (ISB), left, and Fred Ramsdell, co-founder and chair of Sonoma Biotherapeutic’s scientific advisory board, won the 2025 Nobel ...

Sakaguchi, now a distinguished professor at Osaka University's Immunology Frontier Research Center in Japan, was recognized along with Mary E. Brunkow of the Institute for Systems Biology in Seattle ...